Within the COVID-19 positive pandemic group, IBS was identified in 21 cases (91.3%) and AM in two cases (8.7%), while within the COVID-19 negative pandemic group, IBS cases were present in only six cases (54.5%), followed by FD and AM with two cases (18.2%) and FAP-NOS in one case (9.1%) (Table 2, Figure 1B). The gene discussed is FAP; the disease is COVID-19.